BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32453443)

  • 1. Patterns of metastases of prostatic ductal adenocarcinoma.
    Ranasinghe WKB; Brooks NA; Elsheshtawi MA; Davis JW; Bathala TK; Tang C; Troncoso P; Aparicio A; Tu SM; Pisters LL; Chapin BF
    Cancer; 2020 Aug; 126(16):3667-3673. PubMed ID: 32453443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study.
    Seipel AH; Samaratunga H; Delahunt B; Wiklund P; Clements M; Egevad L
    APMIS; 2016 Apr; 124(4):263-70. PubMed ID: 26778368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features.
    Seipel AH; Delahunt B; Samaratunga H; Egevad L
    Pathology; 2016 Aug; 48(5):398-405. PubMed ID: 27321992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
    Zagars GK; Pollack A; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing the diagnosis and management of ductal prostate cancer.
    Ranasinghe W; Shapiro DD; Zhang M; Bathala T; Navone N; Thompson TC; Broom B; Aparicio A; Tu SM; Tang C; Davis JW; Pisters L; Chapin BF
    Nat Rev Urol; 2021 Jun; 18(6):337-358. PubMed ID: 33824525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy.
    Robertson NL; Sala E; Benz M; Landa J; Scardino P; Scher HI; Hricak H; Vargas HA
    J Urol; 2017 Jul; 198(1):65-70. PubMed ID: 28216327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens.
    Seipel AH; Wiklund F; Wiklund NP; Egevad L
    Virchows Arch; 2013 Apr; 462(4):429-36. PubMed ID: 23443941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local and metastatic curative radiotherapy in patients with de novo oligometastatic prostate cancer.
    Reverberi C; Massaro M; Osti MF; Anzellini D; Marinelli L; Montalto A; De Sanctis V; Valeriani M
    Sci Rep; 2020 Oct; 10(1):17471. PubMed ID: 33060732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure prostatic papillary adenocarcinoma with ductal features.
    Yamashita S; Inaba Y; Soma F; Katayama Y
    Hinyokika Kiyo; 2005 Mar; 51(3):207-9; discussion 210. PubMed ID: 15852679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection rates of nonpalpable prostate cancer in Korean men with prostate-specific antigen levels between 2.5 and 4.0 ng/mL.
    Kim HS; Jeon SS; Choi JD; Kim W; Han DH; Jeong BC; Seo SI; Lee KS; Lee SW; Lee HM; Choi HY
    Urology; 2010 Oct; 76(4):919-22. PubMed ID: 20303152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
    Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
    J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic outcomes at 10 years following robotic radical prostatectomy.
    Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
    Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management.
    Ranasinha N; Omer A; Philippou Y; Harriss E; Davies L; Chow K; Chetta PM; Erickson A; Rajakumar T; Mills IG; Bryant RJ; Hamdy FC; Murphy DG; Loda M; Hovens CM; Corcoran NM; Verrill C; Lamb AD
    BJUI Compass; 2021 Jan; 2(1):13-23. PubMed ID: 35474657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
    Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA
    Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy.
    Silverman JM; Krebs TL
    AJR Am J Roentgenol; 1997 Feb; 168(2):379-85. PubMed ID: 9016212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
    Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD
    Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer.
    Murata Y; Tatsugami K; Yoshikawa M; Hamaguchi M; Yamada S; Hayakawa Y; Ueda K; Momosaki S; Sakamoto N
    Int J Urol; 2018 Mar; 25(3):284-289. PubMed ID: 29315854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension.
    Samaratunga H; Duffy D; Yaxley J; Delahunt B
    Hum Pathol; 2010 Feb; 41(2):281-5. PubMed ID: 20004936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
    Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
    Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
    Klein EA; Yousefi K; Haddad Z; Choeurng V; Buerki C; Stephenson AJ; Li J; Kattan MW; Magi-Galluzzi C; Davicioni E
    Eur Urol; 2015 Apr; 67(4):778-86. PubMed ID: 25466945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.